ArticleCancer gene therapy2022

Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias.

Kuan-Wei Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.